Article metrics
PDF
Other content recommended for you
- Unrealistic optimism and the ethics of phase I cancer research
- Understanding people’s ‘unrealistic optimism’ about clinical research participation
- Phase 1 oncology trials and informed consent
- Perceptions of control and unrealistic optimism in early-phase cancer trials
- Informed consent for early-phase clinical trials: therapeutic misestimation, unrealistic optimism and appreciation
- Therapeutic appropriation: a new concept in the ethics of clinical research
- Phase I oncology trials: why the therapeutic misconception will not go away
- Navigating choice in the face of uncertainty: using a theory informed qualitative approach to identifying potential patient barriers and enablers to participating in an early phase chimeric antigen receptor T (CAR-T) cell therapy trial
- Faith, Hope And (No) Clarity
- Therapeutic optimism in the consent forms of phase 1 gene transfer trials: an empirical analysis